Viemed Healthcare, Inc. (NASDAQ: VMD) reported first-quarter results for 2026 that demonstrate improving growth quality, according to an update from Stonegate Capital Partners. The company is seeing increased contributions from sleep, resupply, and maternal health segments, which are reducing its dependence on legacy ventilation and enhancing capital efficiency. While ventilation services are navigating the transition related to the National Coverage Determination (NCD), new-start activity and compliance are improving, although turnover continues to pressure the census.
Key financial metrics underscore the shift. Cash flow from operations (CFFO) rose to $8.1 million in the quarter, up from $2.9 million in the same period last year. Trailing twelve-month free cash flow (TTM FCF) increased to $36.3 million from $23.3 million at year-end 2025. This improvement in FCF conversion is attributed to the scaling of sleep, resupply, and maternal health services.
The revenue mix is evolving favorably. Ventilator rentals declined to 46.9% of total revenue from 54.4% in the prior year, while commercial payor revenue increased to 23% from 17%. Sleep and resupply remain the clearest growth drivers. Positive airway pressure (PAP) patients grew 57% year-over-year to 35,938, new patient starts increased by 42%, and resupply patients rose 47% year-over-year.
These trends indicate that Viemed is successfully diversifying its revenue base and improving operational efficiency, which could lead to more sustainable growth. For investors, the stronger FCF conversion and reduced reliance on a single segment may signal lower risk and better long-term value creation. The company's ability to scale sleep and resupply services while managing the ventilation transition positions it to capitalize on broader healthcare trends toward home-based care and chronic disease management.
The full announcement, including additional details and visuals, is available from Stonegate Capital Partners. Stonegate Capital Partners is a capital markets advisory firm providing investor relations and equity research services. Its affiliate, Stonegate Capital Markets, offers investment banking and capital raising for public and private companies.
